Infusion Associates (IA), a provider of medically prescribed outpatient infusion and injection therapies in the Midwest, announced the promotion of executive leadership member Andrew Volk from senior VP of revenue cycle to senior VP of corporate development & strategy.
A licensed pharmacist and board-certified in pharmacotherapeutic specialties, Volk joined Infusion Associates in 2020 to manage the company’s supply chain and revenue cycle across all sites of service. In his new role, Volk will use his robust knowledge of the infusion industry and payer landscape to focus on payer relations, mergers, and acquisitions, market analysis and strategy development among other key business development activities.
“Andrew’s unique combination of skills and experiences cover both revenue and cost sides of our business. His understanding of group purchasing organizations, the FDA pipeline of infusible drugs, health plan priorities, value-based contracting and the value of longitudinal medical data of patient’s with chronic diseases has helped define our growth strategies,” says Chuck Jett, CEO at Infusion Associates. “I look forward to the ongoing impact he will make as we advance the company in 2022 and beyond.”
Volk attended pharmacy school at Nova Southeastern University and has most recently completed his MBA at Cornerstone University. He has worked in pharmacy, supply chain, and infusion services at both Sinai Health System in Chicago as well as Spectrum Health in West Michigan.